PHRI Scientist Ashkan Shoamanesh is among 32 professionals to make the first cohort of the World Stroke Organization (WSO)’s Future Leaders Programme. The initiative, connecting global talent for future cerebrovscular healthcare provision, features key research projects in: stroke prevention (primary and secondary); acute stroke care; post-acute care and rehabilitation; and global and regional priority actions.
Ashkan Shoamanesh
WSO Future Leaders are comprised of professionals from 23 countries, half of those outside the Americas and Europe – with 28% from sub-Saharan Africa and Middle East/Mediterranean (28%), and 22% from Asia and Oceania.
The WSO Future Leaders are split 50/50 by gender, and the majority of specialty (69%) is neurology, followd by physiotheraphy (16%) and the rest split between cardiology, epidemiology, OT, nursing, speech therapy, and general medicine.
Ashkan Shoamanesh, representing Canada in the WSO cohort, is an Assistant Professor of Medicine (neurology) at McMaster University, and Director, Stroke Fellowship Program at Hamilton Health Sciences (HHS) and McMaster, a neurologist at HHS, as well as his role leading hemorrhagic stroke research at PHRI.
His research is focused on improving the clinical care of patients with stroke or who are at risk for stroke resulting from blood vessel rupture and bleeding into the brain. Ashkan is the founding Chair of the Canadian Hemorrhagic Stroke Trials Initiative (CoHESIVE) and leads as principal investigator the global phase III ENRICH-AF trial investigating optimal stroke prevention in intracranial hemorrhage survivors with atrial fibrillation in 22 countries.
